Placebo to BAY3283142
Sponsors
Bayer
Conditions
Arterial HypertensionChronic Kidney DiseaseHypertension
Phase 1
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
CompletedNCT05491642
Start: 2022-09-08End: 2023-04-28Updated: 2023-05-17
A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure
CompletedNCT06428825
Start: 2024-08-16End: 2025-11-21Updated: 2026-06-16